24227448|t|A randomized, double-blind pilot study of dexmedetomidine versus midazolam for intensive care unit sedation: patient recall of their experiences and short-term psychological outcomes.
24227448|a|INTRODUCTION: Sedation with dexmedetomidine may facilitate ventilator liberation and limit the occurrence of delirium. No trial has assessed patient recall or the development of psychological outcomes after dexmedetomidine sedation. This pilot study evaluated whether transitioning benzodiazepine sedation to dexmedetomidine alters patient recall and the incidence of anxiety, depression, or acute stress disorder (ASD). METHODS: This investigation was a randomized, double-blind, single-center study. Existing continuous benzodiazepine sedation was converted to dexmedetomidine or midazolam when patients qualified for daily awakenings. Sedation was titrated to achieve Riker sedation agitation scores of 3 to 4. The intensive care unit (ICU) Stressful Experiences Questionnaire, hospital anxiety and depression scale, and the impact of event scale-revised were administered before hospital discharge to assess recall, anxiety, depression, and manifestations of ASD. RESULTS: A total of 11 patients received dexmedetomidine, and 12 patients received midazolam. Median dosing was 0.61 microg/kg/h for 3.5 days for dexmedetomidine and 3.7 mg/h for 3 days for midazolam. Attainment of goal sedation and analgesia was similar; however, more dexmedetomidine patients experienced agitation and pain. The median duration of mechanical ventilation from study drug initiation to extubation was 3.4 days in dexmedetomidine patients and 2.9 days in midazolam patients. Dexmedetomidine patients remembered 18.5 experiences compared with 8.5 in midazolam patients (P = .015). Rates of anxiety and depression were similar. In all, 5 (62.5%) dexmedetomidine patients and 1 (12.5%) midazolam patient manifested ASD (P = .063), and 1 dexmedetomidine patient and 5 midazolam patients developed new-onset delirium (P = .07). Hypotension occurred in 10 (90.9%) dexmedotomidine patients and 6 (50%) midazolam patients (P = .069). CONCLUSIONS: Transitioning benzodiazepine sedation to dexmedetomidine when patients qualify for daily awakenings may reduce the development of delirium and facilitate remembrance of ICU experiences but may lead to manifestations of ASD. Monitoring hypotension is required for both the sedatives. Additional comparative studies focusing on the long-term impact of ICU recall and psychological outcomes are needed.
24227448	42	57	dexmedetomidine	Chemical	MESH:D020927
24227448	65	74	midazolam	Chemical	MESH:D008874
24227448	109	116	patient	Species	9606
24227448	212	227	dexmedetomidine	Chemical	MESH:D020927
24227448	293	301	delirium	Disease	MESH:D003693
24227448	325	332	patient	Species	9606
24227448	391	406	dexmedetomidine	Chemical	MESH:D020927
24227448	466	480	benzodiazepine	Chemical	MESH:D001569
24227448	493	508	dexmedetomidine	Chemical	MESH:D020927
24227448	516	523	patient	Species	9606
24227448	552	559	anxiety	Disease	MESH:D001007
24227448	561	571	depression	Disease	MESH:D003866
24227448	576	597	acute stress disorder	Disease	MESH:D040701
24227448	599	602	ASD	Disease	MESH:D040701
24227448	706	720	benzodiazepine	Chemical	MESH:D001569
24227448	747	762	dexmedetomidine	Chemical	MESH:D020927
24227448	766	775	midazolam	Chemical	MESH:D008874
24227448	781	789	patients	Species	9606
24227448	870	879	agitation	Disease	MESH:D011595
24227448	974	981	anxiety	Disease	MESH:D001007
24227448	986	996	depression	Disease	MESH:D003866
24227448	1104	1111	anxiety	Disease	MESH:D001007
24227448	1113	1123	depression	Disease	MESH:D003866
24227448	1147	1150	ASD	Disease	MESH:D040701
24227448	1175	1183	patients	Species	9606
24227448	1193	1208	dexmedetomidine	Chemical	MESH:D020927
24227448	1217	1225	patients	Species	9606
24227448	1235	1244	midazolam	Chemical	MESH:D008874
24227448	1298	1313	dexmedetomidine	Chemical	MESH:D020927
24227448	1342	1351	midazolam	Chemical	MESH:D008874
24227448	1422	1437	dexmedetomidine	Chemical	MESH:D020927
24227448	1438	1446	patients	Species	9606
24227448	1459	1468	agitation	Disease	MESH:D011595
24227448	1473	1477	pain	Disease	MESH:D010146
24227448	1582	1597	dexmedetomidine	Chemical	MESH:D020927
24227448	1598	1606	patients	Species	9606
24227448	1623	1632	midazolam	Chemical	MESH:D008874
24227448	1633	1641	patients	Species	9606
24227448	1643	1658	Dexmedetomidine	Chemical	MESH:D020927
24227448	1659	1667	patients	Species	9606
24227448	1717	1726	midazolam	Chemical	MESH:D008874
24227448	1727	1735	patients	Species	9606
24227448	1757	1764	anxiety	Disease	MESH:D001007
24227448	1769	1779	depression	Disease	MESH:D003866
24227448	1812	1827	dexmedetomidine	Chemical	MESH:D020927
24227448	1828	1836	patients	Species	9606
24227448	1851	1860	midazolam	Chemical	MESH:D008874
24227448	1861	1868	patient	Species	9606
24227448	1880	1883	ASD	Disease	MESH:D040701
24227448	1902	1917	dexmedetomidine	Chemical	MESH:D020927
24227448	1918	1925	patient	Species	9606
24227448	1932	1941	midazolam	Chemical	MESH:D008874
24227448	1942	1950	patients	Species	9606
24227448	1971	1979	delirium	Disease	MESH:D003693
24227448	1991	2002	Hypotension	Disease	MESH:D007022
24227448	2026	2041	dexmedotomidine	Chemical	-
24227448	2042	2050	patients	Species	9606
24227448	2063	2072	midazolam	Chemical	MESH:D008874
24227448	2073	2081	patients	Species	9606
24227448	2121	2135	benzodiazepine	Chemical	MESH:D001569
24227448	2148	2163	dexmedetomidine	Chemical	MESH:D020927
24227448	2169	2177	patients	Species	9606
24227448	2237	2245	delirium	Disease	MESH:D003693
24227448	2326	2329	ASD	Disease	MESH:D040701
24227448	2342	2353	hypotension	Disease	MESH:D007022
24227448	Positive_Correlation	MESH:D008874	MESH:D011595
24227448	Positive_Correlation	MESH:D001569	MESH:D003693
24227448	Negative_Correlation	MESH:D008874	MESH:D040701
24227448	Positive_Correlation	MESH:D020927	MESH:D007022
24227448	Positive_Correlation	MESH:D020927	MESH:D003866
24227448	Association	MESH:D020927	MESH:D010146
24227448	Comparison	MESH:D008874	MESH:D020927
24227448	Positive_Correlation	MESH:D001569	MESH:D007022
24227448	Comparison	MESH:D001569	MESH:D008874
24227448	Positive_Correlation	MESH:D008874	MESH:D007022
24227448	Positive_Correlation	MESH:D008874	MESH:D003693
24227448	Comparison	MESH:D001569	MESH:D020927
24227448	Positive_Correlation	MESH:D020927	MESH:D011595
24227448	Negative_Correlation	MESH:D020927	MESH:D040701
24227448	Negative_Correlation	MESH:D020927	MESH:D003693

